Instituto de Investigación Biomédica de A Coruña (INIBIC)
Research center
Cedars-Sinai Medical Center
Los Ángeles, Estados UnidosPublications in collaboration with researchers from Cedars-Sinai Medical Center (15)
2024
-
Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4
Journal of Cardiac Failure
-
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial
Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473
-
Molecular states associated with dysfunction and graft loss in heart transplants
Journal of Heart and Lung Transplantation, Vol. 43, Núm. 3, pp. 508-518
-
Standard-of-Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM
Journal of the American College of Cardiology, Vol. 84, Núm. 19, pp. 1839-1849
2023
-
Impact of Complete Revascularization in the ISCHEMIA Trial
Journal of the American College of Cardiology, Vol. 82, Núm. 12, pp. 1175-1188
-
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology, Vol. 81, Núm. 1, pp. 34-45
2022
-
Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial
American Heart Journal, Vol. 248, pp. 72-83
-
Many heart transplant biopsies currently diagnosed as no rejection have mild molecular antibody-mediated rejection-related changes
Journal of Heart and Lung Transplantation, Vol. 41, Núm. 3, pp. 334-344
-
Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial
Journal of the American College of Cardiology, Vol. 79, Núm. 7, pp. 651-661
2020
-
Initial invasive or conservative strategy for stable coronary disease
New England Journal of Medicine, Vol. 382, Núm. 15, pp. 1395-1407
2019
-
An integrated molecular diagnostic report for heart transplant biopsies using an ensemble of diagnostic algorithms
Journal of Heart and Lung Transplantation, Vol. 38, Núm. 6, pp. 636-646
-
Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT Study
Clinical Therapeutics, Vol. 41, Núm. 1, pp. 130-136
2017
-
Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement
Pituitary, Vol. 20, Núm. 5, pp. 489-498
-
Heart transplant centers with multidisciplinary team show a higher level of chronic illness management – Findings from the International BRIGHT Study
Heart and Lung, Vol. 46, Núm. 5, pp. 351-356
2011
-
Report from a consensus conference on antibody-mediated rejection in heart transplantation
Journal of Heart and Lung Transplantation, Vol. 30, Núm. 3, pp. 252-269